Confocal Laser Scanning Microscope is Dark-Room Free
|
By LabMedica International staff writers Posted on 22 Dec 2008 |
|
A self-contained confocal laser scanning microscope system is contained in a compact main unit with multiple integrated functions. The system can be used within a small corner of a brightly lit laboratory
To use the system, scientists insert the specimen and follow easy, step-by-step guides offered on-screen. Images are saved automatically, and the system has mechanisms to help preserve living cells that allow the user to walk away temporarily.
The high performance system called FluoView FV10i (FV10i) can capture images from 10x to 600x magnification, with high-performance 10x and 60x objectives and a digital zoom. The microscope has four compact diode laser units for power savings and longer life. The scanning detector automatically sets conditions according to the particular fluorescence dye being used, so that imaging is performed under ideal conditions for each fluorescence probe.
The FV10i is the latest innovation in the FluoView confocal microscope system series. Engineered to work "right out of the box," it was designed for scientists in clinical, pharmaceutical, stem cell, cell biology, and other laboratories.
The microscope is suitable for individual users, smaller biologic facilities, labs where a confocal specialist is not always available, and any user who needs to do confocal imaging of living cells and tissues.
Available from Olympus America Inc., (Center Valley, PA, USA), the FV10i offers Olympus UIS2 objectives for peak optical performance in the smallest confocal laser scanning microscope footprint available, all with no darkroom or anti-vibration table required. An optional version of the instrument was specifically designed for time-lapse imaging.
"This [the Olympus FV10i] is in many ways the confocal system that biologists have requested for years," said Dennis Donley of Olympus America's scientific equipment group. "It is 'out of the box' thinking of the best kind: instant setup, intuitive performance, small footprint, no special training, cost effective, darkroom-free, and world-class results."
Related Links:
Olympus America Inc
To use the system, scientists insert the specimen and follow easy, step-by-step guides offered on-screen. Images are saved automatically, and the system has mechanisms to help preserve living cells that allow the user to walk away temporarily.
The high performance system called FluoView FV10i (FV10i) can capture images from 10x to 600x magnification, with high-performance 10x and 60x objectives and a digital zoom. The microscope has four compact diode laser units for power savings and longer life. The scanning detector automatically sets conditions according to the particular fluorescence dye being used, so that imaging is performed under ideal conditions for each fluorescence probe.
The FV10i is the latest innovation in the FluoView confocal microscope system series. Engineered to work "right out of the box," it was designed for scientists in clinical, pharmaceutical, stem cell, cell biology, and other laboratories.
The microscope is suitable for individual users, smaller biologic facilities, labs where a confocal specialist is not always available, and any user who needs to do confocal imaging of living cells and tissues.
Available from Olympus America Inc., (Center Valley, PA, USA), the FV10i offers Olympus UIS2 objectives for peak optical performance in the smallest confocal laser scanning microscope footprint available, all with no darkroom or anti-vibration table required. An optional version of the instrument was specifically designed for time-lapse imaging.
"This [the Olympus FV10i] is in many ways the confocal system that biologists have requested for years," said Dennis Donley of Olympus America's scientific equipment group. "It is 'out of the box' thinking of the best kind: instant setup, intuitive performance, small footprint, no special training, cost effective, darkroom-free, and world-class results."
Related Links:
Olympus America Inc
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Silver Member
ACTH Assay
ACTH ELISA
New
Mumps Virus Test
ZEUS ELISA Mumps IgG Test System
Latest Technology News
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
- Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management
- First AI-Powered Blood Test Identifies Patients in Earliest Stage of Breast Cancer
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more
Molecular Diagnostics
view channel
Cheap Cell-Free DNA Based Test Accurately Predicts Preterm Birth
Preterm birth (PTB) occurs in around 11% of all births globally, leading to considerable morbidity and mortality for both mothers and their newborns. Identifying pregnancies at risk of PTB early in gestation... Read more
RNA Blood Test Detects Cancers and Resistance to Treatment
A newly developed blood test offers the ability to detect cancer, understand how cancer resists treatments, and assess tissue damage from non-cancerous conditions. This innovative test, created by researchers... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Pathology
view channel
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read more
Spit Test More Accurate at Identifying Future Prostate Cancer Risk
Currently, blood tests that measure the level of a protein called prostate-specific antigen (PSA) are commonly used to identify men at higher risk for prostate cancer. This test is typically used based... Read more
DNA Nanotechnology Boosts Sensitivity of Test Strips
Since the Covid-19 pandemic, most people have become familiar with paper-based rapid test strips, also known as lateral flow immunoassays (LFIAs). These tests are used to quickly detect biomarkers that... Read more
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
